Biomatrix (BXM) Looking Great Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John McCarthy who wrote (164)	11/3/1997 8:22:00 PM
From: pkwknk	Read Replies (3) of 569

...keep something in mind: AHP/Wyeth expects to sell kit for$ 500 to DOCTOR not pharmacy...that means the MD has to buy , say 20 kits at #500/per for 10 G--no way he will take that $$$inventory risk of capital expense and wait fro who's reimbursement??? the insurer/medicare?? the patient??.. if Medicare grants a CPT code for say the doing of the injection (maybe $50-70), then the "liquid prosthesis" as it is referred to, still has to be paid for, and the patient will have to part with $500+ to the MD ( promoted as similar cost and less gastric irritation than 6 months worth of NSAI drugs)...AHP has to think this one out, and I am trying to find out from my sources and the co if they have...if all the risk the ortho takes is a few minutes time for 3 visits at say $50-70-/pop and retains the patient until the inevitable total knee replacement, he's a happy guy, and the sales numbers for this are monstrous....but IMHO you need that wrinkle worked out, otherwise MD's will not seek out product ( unless of course you rely solely on consumer demand, and dont bet on that whenit costs them $500 up front- they will only do that if MD first pushes it as a must)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next